Kodiak Sciences, Inc. (KOD)
35.02
-2.00
(-5.40%)
USD |
NASDAQ |
May 18, 16:00
35.05
+0.03
(+0.09%)
After-Hours: 20:00
Kodiak Sciences Research and Development Expense (Quarterly) : 48.55M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Tango Therapeutics, Inc. | 33.07M |
| Revolution Medicines, Inc. | 341.62M |
| Catalyst Pharmaceuticals, Inc. | 2.661M |
| Madrigal Pharmaceuticals, Inc. | 108.31M |
| ADMA Biologics, Inc. | 2.597M |